Abstract
In addition to conventional hetero-tetrameric antibodies, the adaptive immune repertoire of camelids comprises the so-called heavy chain-only antibodies devoid of light chains. Consequently, antigen binding is mediated solely by the variable domain of the heavy chain, referred to as VHH. In recent years, these single-domain moieties emerged as promising tools for biotechnological and biomedical applications. In this chapter, we describe the generation of VHH antibody yeast surface display libraries from immunized Alpacas and Lamas as well as the facile isolation of antigen-specific molecules in a convenient fluorescence-activated cell sorting (FACS)-based selection process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hamers-Casterman C, Atarhouch T, Muyldermans S et al (1993) Naturally occurring antibodies devoid of light chains. Nature 363:446–448
Zielonka S, Empting M, Grzeschik J et al (2015) Structural insights and biomedical potential of IgNAR scaffolds from sharks. MAbs 7:15–25
Arezumand R, Alibakhshi A, Ranjbari J et al (2017) Nanobodies as novel agents for targeting angiogenesis in solid cancers. Front Immunol 8:1746
Könning D, Zielonka S, Grzeschik J et al (2017) Camelid and shark single domain antibodies: structural features and therapeutic potential. Curr Opin Struct Biol 45:10–16
Wesolowski J, Alzogaray V, Reyelt J et al (2009) Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med Microbiol Immunol 198:157–174
Jähnichen S, Blanchetot C, Maussang D et al (2010) CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells. Proc Natl Acad Sci U S A 107:20565–20570
Maussang D, Mujić-Delić A, Descamps FJ et al (2013) Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivo. J Biol Chem 288:29562–29572
Nguyen VK, Hamers R, Wyns L et al (2000) Camel heavy-chain antibodies: diverse germline VHH and specific mechanisms enlarge the antigen-binding repertoire. EMBO J 19:921–930
Muyldermans S, Smider VV (2016) Distinct antibody species: structural differences creating therapeutic opportunities. Curr Opin Immunol 40:7–13
Krah S, Schröter C, Zielonka S et al (2016) Single-domain antibodies for biomedical applications. Immunopharmacol Immunotoxicol 38:21–28
Conrath KE, Wernery U, Muyldermans S et al (2003) Emergence and evolution of functional heavy-chain antibodies in Camelidae. Dev Comp Immunol 27:87–103
Vincke C, Loris R, Saerens D et al (2009) General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold. J Biol Chem 284:3273–3284
Tijink BM, Laeremans T, Budde M et al (2008) Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology. Mol Cancer Ther 7:2288–2297
Helma J, Cardoso MC, Muyldermans S et al (2015) Nanobodies and recombinant binders in cell biology. J Cell Biol 209:633–644
Alvarez-Cienfuegos A, Nuñez-Prado N, Compte M et al (2016) Intramolecular trimerization, a novel strategy for making multispecific antibodies with controlled orientation of the antigen binding domains. Sci Rep 6:28643
Desmyter A, Spinelli S, Boutton C et al (2017) Neutralization of human interleukin 23 by multivalent nanobodies explained by the structure of cytokine–nanobody complex. Front Immunol 8:884
Goldman E, Liu J, Bernstein R et al (2009) Ricin detection using phage displayed single domain antibodies. Sensors 9:542–555
Yan J, Li G, Hu Y et al (2014) Construction of a synthetic phage-displayed Nanobody library with CDR3 regions randomized by trinucleotide cassettes for diagnostic applications. J Transl Med 12:343
Bencurova E, Pulzova L, Flachbartova Z et al (2015) A rapid and simple pipeline for synthesis of mRNA–ribosome–V H H complexes used in single-domain antibody ribosome display. Mol BioSyst 11:1515–1524
Romao E, Morales-Yanez F, Hu Y et al (2016) Identification of useful nanobodies by phage display of immune single domain libraries derived from camelid heavy chain antibodies. Curr Pharm Des 22:6500–6518
Cavallari M (2017) Rapid and direct VHH and target identification by staphylococcal surface display libraries. Int J Mol Sci 18:1507
Eden T, Menzel S, Wesolowski J et al (2018) A cDNA immunization strategy to generate nanobodies against membrane proteins in native conformation. Front Immunol 8:1989
Wu Y, Jiang S, Ying T (2017) Single-domain antibodies as therapeutics against human viral diseases. Front Immunol 8:1802
Pardon E, Laeremans T, Triest S et al (2014) A general protocol for the generation of Nanobodies for structural biology. Nat Protoc 9:674–693
McMahon C, Baier AS, Pascolutti R et al (2018) Yeast surface display platform for rapid discovery of conformationally selective nanobodies. Nat Struct Mol Biol 25:289–296
Boder ET, Wittrup KD (1997) Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol 15:553–557
Lu Z-J (2012) Frontier of therapeutic antibody discovery: The challenges and how to face them. World J Biol Chem 3:187
Doerner A, Rhiel L, Zielonka S et al (2014) Therapeutic antibody engineering by high efficiency cell screening. FEBS Lett 588:278–287
Zielonka S, Weber N, Becker S et al (2014) Shark Attack: high affinity binding proteins derived from shark vNAR domains by stepwise in vitro affinity maturation. J Biotechnol 191:236–245
Zielonka S, Empting M, Könning D et al (2015) The shark strikes twice: hypervariable loop 2 of shark IgNAR antibody variable domains and its potential to function as an autonomous paratope. Mar Biotechnol (NY) 17:386–392
Grzeschik J, Könning D, Hinz SC et al (2018) Generation of semi-synthetic shark IgNAR single-domain antibody libraries. Methods Mol Biol 1701:147–167
Acknowledgments
We like to thank Preclinics GmbH for collaborating on this project.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Roth, L. et al. (2020). Isolation of Antigen-Specific VHH Single-Domain Antibodies by Combining Animal Immunization with Yeast Surface Display. In: Zielonka, S., Krah, S. (eds) Genotype Phenotype Coupling. Methods in Molecular Biology, vol 2070. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9853-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9853-1_10
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9852-4
Online ISBN: 978-1-4939-9853-1
eBook Packages: Springer Protocols